Autosomal dominant Alport syndrome: genes and variants
Explore variant evidence for Autosomal dominant Alport syndrome across 3 analyzed proteins (COL4A3, COL4A4, COL4A5). Linked ClinVar records include 138 pathogenic or likely pathogenic variants, 151 variants of uncertain significance and 110 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autosomal dominant Alport syndrome
COL4A3: Collagen alpha-3(IV) chain
It contributes to the alpha3-alpha4-alpha5 type IV collagen network that forms the specialized basement membrane of the renal glomerulus, cochlea, and eye. Pathogenic variants cause Alport-spectrum disease and thin-basement-membrane nephropathy, with variable kidney and hearing involvement.
131 ClinVar pathogenic / likely pathogenic and 252 uncertain variants in COL4A3 have source records linked to Autosomal dominant Alport syndrome. Association strength is not clinical gene validity.
COL4A4: Collagen alpha-4(IV) chain
It combines with the alpha3 and alpha5 chains to form the mature type IV collagen network of glomerular, cochlear, and ocular basement membranes. Pathogenic variants cause autosomal Alport-spectrum disease and can present with isolated persistent hematuria.
6 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in COL4A4 have source records linked to Autosomal dominant Alport syndrome. Association strength is not clinical gene validity.
COL4A5: Collagen alpha-5(IV) chain
It is essential for the alpha3-alpha4-alpha5 type IV collagen network that gives glomerular and cochlear basement membranes their mature mechanical properties. Pathogenic variants cause X-linked Alport syndrome, with progressive kidney disease, hearing loss, and characteristic ocular findings.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in COL4A5 have source records linked to Autosomal dominant Alport syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant Alport syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL4A3 G395R | 395 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G532C | 532 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G532D | 532 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G730E | 730 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G777D | 777 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G777V | 777 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1152S | 1152 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1155D | 1155 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1155S | 1155 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1207R | 1207 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1228V | 1228 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1322C | 1322 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G395E | 395 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1152R | 1152 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G230D | 230 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G265R | 265 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G336C | 336 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G452R | 452 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G458R | 458 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G493R | 493 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G520D | 520 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G563R | 563 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G712V | 712 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G715S | 715 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G736V | 736 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G783R | 783 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G795E | 795 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G883R | 883 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G889V | 889 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G922E | 922 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G997E | 997 | Cell attachment site | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1045V | 1045 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1198D | 1198 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1385E | 1385 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G148V | 148 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G265E | 265 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G315S | 315 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G490R | 490 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G634R | 634 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G985E | 985 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1086E | 1086 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1104R | 1104 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1207E | 1207 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1228R | 1228 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1322S | 1322 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1334E | 1334 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 L1598R | 1598 | Collagen IV NC1 | Pathogenic / likely pathogenic (★★) |
| COL4A3 C1616Y | 1616 | Collagen IV NC1 | Pathogenic / likely pathogenic (★★) |
| COL4A3 G55R | 55 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G97R | 97 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G115A | 115 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G439S | 439 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G458V | 458 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G467R | 467 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G619R | 619 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G637R | 637 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1003R | 1003 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1143R | 1143 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1418R | 1418 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G183C | 183 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
Showing 60 of 138.
Uncertain variants prioritized for review in Autosomal dominant Alport syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| COL4A3 G955E | 955 | Triple-helical region | Conflicting reports (★) | +7: G955V at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.983 |
| COL4A3 G532S | 532 | Triple-helical region | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G532C at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.975 |
| COL4A3 G868R | 868 | Triple-helical region | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G868E at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.942 |
| COL4A3 G985V | 985 | Triple-helical region | Conflicting reports (★) | +7: 3 other pathogenic changes within 3 positions; G985E at the same position is pathogenic; seen in 4.1e-06 of gnomAD DNA copies; REVEL 0.951 |
| COL4A3 G183D | 183 | Triple-helical region | Uncertain (★) | +7: G183C at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.978 |
| COL4A3 G1152D | 1152 | Triple-helical region | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; G1152R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.86 |
Which prediction tools work for Autosomal dominant Alport syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 99 out of 100
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 99 out of 100
- phyloP: 98 out of 100
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 97 out of 100
- PolyPhen-2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 96 out of 100
- CADD: 95 out of 100
- MetaSVM: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 57 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Alport syndrome also has ClinVar records linked to COL4A3 variants; they fall partly in the same places as the Autosomal dominant Alport syndrome variants (128 pathogenic / likely pathogenic).
- Autosomal recessive Alport syndrome also has ClinVar records linked to COL4A3 variants; they fall partly in the same places as the Autosomal dominant Alport syndrome variants (32 pathogenic / likely pathogenic).
- Autosomal recessive Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Autosomal dominant Alport syndrome variants (99 pathogenic / likely pathogenic).
- Benign familial hematuria also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Autosomal dominant Alport syndrome variants (65 pathogenic / likely pathogenic).
- Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Autosomal dominant Alport syndrome variants (57 pathogenic / likely pathogenic).
- X-linked Alport syndrome also has ClinVar records linked to COL4A5 variants; they fall mostly in different places as the Autosomal dominant Alport syndrome variants (341 pathogenic / likely pathogenic).
- Alport syndrome also has ClinVar records linked to COL4A5 variants; they fall mostly in different places as the Autosomal dominant Alport syndrome variants (14 pathogenic / likely pathogenic).
Diseases related to Autosomal dominant Alport syndrome
- Alport syndrome, also linked to COL4A3, COL4A4 and COL4A5
- Benign familial hematuria, also linked to COL4A3 and COL4A4
- Autosomal recessive Alport syndrome, also linked to COL4A3 and COL4A4
- Nephrotic syndrome, also linked to COL4A4 and COL4A5
- Benign neonatal seizures, also linked to COL4A3 and COL4A4
- Kidney disorder, also linked to COL4A3 and COL4A5
- X-linked Alport syndrome, also linked to COL4A5
- Rare genetic deafness, also linked to COL4A5
- Polycystic kidney disease, also linked to COL4A4
- Monogenic hearing loss, also linked to COL4A5
- Steroid-resistant nephrotic syndrome, also linked to COL4A5
- Isolated macular dystrophy, also linked to COL4A5
Frequently asked questions
Which genes have records linked to Autosomal dominant Alport syndrome?
This view contains 3 analyzed proteins: COL4A3, COL4A4, COL4A5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 138 pathogenic or likely pathogenic variants, 151 variants of uncertain significance and 110 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 6 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 437 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center